Bigger sales forces for smaller companies
Article Abstract:
Alza Corp. will triple the size of its sales force to 360 and venture into marketing its own products. The pharmaceutical company that specializes in the development of drug-delivery systems, will concentrate on the promotion and sale of its incontinence drug, Ditropan XL, which is expected to obtain FDA approval before the end of 1998. Dura Pharmaceuticals is likewise expanding its sales force to 450 representatives from 355 detail persons. Dura, which specializes in bronchopulmonary products, has recently obtained exclusive marketing rights for the single-source tuberculosis drug, Myambutol, from American Home Products Corp. for $33.5 million.
Publication Name: Medical Marketing & Media
Subject: Health care industry
ISSN: 0025-7354
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
After Redux? Here's how Meridia was introduced into a "tainted" market
Article Abstract:
Knoll Pharmaceutical had engaged in significant preparation before it released its new diet medication Meridia into the market without significantly altering its previous marketing strategy. Usually, companies invest a minimum of two years in collaboration with an advertising agency before it introduces a new product. At the same time, the market has never considered prescription anti-obesity medication that highly in the first place. Knoll Pharmaceutical marketing director Joe Loftus indicated that the company aimed to make Meridia part of a patient's planned weight control program supervised by a physician.
Publication Name: Medical Marketing & Media
Subject: Health care industry
ISSN: 0025-7354
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Career survival strategies for materiel managers. Recent initiatives in U.S. hospital supply management
- Abstracts: Summary oral reflective analysis: a method for interview data analysis in feminist qualitative research
- Abstracts: Antimicrobial resistance: implications for the clinician. Hospital-acquired pneumonia and its management
- Abstracts: Where have all the RNs gone?. A holy alliance
- Abstracts: A holy alliance. Tenet bid for Philly hospitals prevails